Latest Insider Transactions at Entrada Therapeutics, Inc. (TRDA)
This section provides a real-time view of insider transactions for Entrada Therapeutics, Inc. (TRDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Entrada Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Entrada Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
400
-0.24%
|
$6,000
$15.01 P/Share
|
|
Dec 28
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
4,521
-2.61%
|
$67,815
$15.01 P/Share
|
|
Dec 27
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
9,669
-2.65%
|
$135,366
$14.92 P/Share
|
|
Dec 08
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,550
-21.61%
|
$81,900
$18.95 P/Share
|
|
Dec 08
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,550
+17.77%
|
$9,100
$2.1 P/Share
|
|
Dec 05
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
200
-1.2%
|
$3,600
$18.05 P/Share
|
|
Dec 05
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+1.18%
|
$400
$2.1 P/Share
|
|
Dec 02
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,910
-14.99%
|
$52,380
$18.2 P/Share
|
|
Dec 02
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,910
+13.03%
|
$5,820
$2.1 P/Share
|
|
Nov 28
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,000
-1.08%
|
$26,000
$13.91 P/Share
|
|
Nov 16
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
200
-1.2%
|
$3,600
$18.1 P/Share
|
|
Nov 16
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+1.18%
|
$400
$2.1 P/Share
|
|
Oct 31
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
2,100
-4.43%
|
$50,400
$24.05 P/Share
|
|
Oct 27
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,000
-1.07%
|
$42,000
$21.66 P/Share
|
|
Oct 26
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,960
-9.87%
|
$104,160
$21.61 P/Share
|
|
Oct 26
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,960
+16.19%
|
$9,920
$2.1 P/Share
|
|
Oct 25
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
12,061
-2.06%
|
$241,220
$20.76 P/Share
|
|
Oct 25
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
9,348
-5.76%
|
$186,960
$20.97 P/Share
|
|
Oct 25
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,040
-10.09%
|
$168,840
$21.36 P/Share
|
|
Oct 25
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,040
+21.85%
|
$16,080
$2.1 P/Share
|
|
Oct 24
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,342
-0.58%
|
$44,498
$19.28 P/Share
|
|
Oct 24
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
2,404
-2.05%
|
$45,676
$19.27 P/Share
|
|
Oct 21
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,786
-1.37%
|
$50,148
$18.28 P/Share
|
|
Oct 21
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
2,771
-4.48%
|
$49,878
$18.29 P/Share
|
|
Oct 20
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
811
-0.4%
|
$14,598
$18.01 P/Share
|
|
Oct 20
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
905
-1.44%
|
$16,290
$18.07 P/Share
|
|
Sep 28
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,122
-13.1%
|
$46,830
$15.25 P/Share
|
|
Sep 28
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,122
+11.58%
|
$6,244
$2.1 P/Share
|
|
Sep 28
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
3,085
-1.48%
|
$46,275
$15.23 P/Share
|
|
Sep 27
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,403
-10.39%
|
$36,045
$15.31 P/Share
|
|
Sep 27
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,403
+9.42%
|
$4,806
$2.1 P/Share
|
|
Sep 27
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
4,419
-1.04%
|
$66,285
$15.43 P/Share
|
|
Sep 26
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
1,544
-1.2%
|
$23,160
$15.79 P/Share
|
|
Sep 26
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,068
-6.53%
|
$46,020
$15.78 P/Share
|
|
Sep 26
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,068
+11.43%
|
$6,136
$2.1 P/Share
|
|
Sep 26
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
3,083
-0.72%
|
$46,245
$15.76 P/Share
|
|
Sep 23
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
939
-4.34%
|
$14,085
$15.09 P/Share
|
|
Sep 23
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
939
+4.16%
|
$1,878
$2.1 P/Share
|
|
Sep 23
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
1,018
-1.56%
|
$15,270
$15.07 P/Share
|
|
Sep 23
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,023
-0.47%
|
$15,345
$15.07 P/Share
|
|
Sep 21
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,341
-13.89%
|
$50,115
$15.08 P/Share
|
|
Sep 21
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,341
+12.19%
|
$6,682
$2.1 P/Share
|
|
Sep 21
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
3,275
-4.77%
|
$49,125
$15.13 P/Share
|
|
Sep 21
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
3,402
-1.55%
|
$51,030
$15.12 P/Share
|
|
Sep 15
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
106
-0.51%
|
$1,590
$15.01 P/Share
|
|
Sep 15
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
106
+0.51%
|
$212
$2.1 P/Share
|
|
Sep 15
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
100
-0.15%
|
$1,500
$15.01 P/Share
|
|
Sep 15
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
200
-0.09%
|
$3,000
$15.04 P/Share
|
|
Sep 09
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
800
-3.72%
|
$12,000
$15.07 P/Share
|
|
Sep 09
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
800
+3.58%
|
$1,600
$2.1 P/Share
|